| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.9M | -26.9% |
| Cost of Revenue | $14.6M | -35.2% |
| Gross Profit | $13.3M | -14.8% |
| R&D Expense | $5.3M | +8.3% |
| SG&A Expense | $13.9M | +11.7% |
| Operating Income | -$22.1M | -25.4% |
| Pre-tax Income | -$25.4M | -22.1% |
| Income Tax | $14K | -58.8% |
| Net Income | -$25.4M | -21.9% |
| EPS (Basic) | -$1.01 | -107.8% |
| EPS (Diluted) | -$1.01 | -198.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.4M | -54.7% |
| Inventory | $2.4M | -25.8% |
| Current Assets | $6.5M | -52.0% |
| Total Assets | $7.6M | -43.9% |
| Current Liabilities | $17.3M | -17.1% |
| Long-term Debt | $17.7M | +186.1% |
| Total Liabilities | $30.1M | +6.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.0M | -102.5% |
| Investing Cash Flow | -$26K | -100.0% |
| Financing Cash Flow | $14.4M | +37.2% |
| -$22.5M |
| -53.2% |